Innate Pharma S.A. (IPHA) Analyst/Investor Day Transcript
Source: SeekingAlpha
2025-10-28 18:21:51 ET
Innate Pharma S.A. (IPHA) Analyst/Investor Day October 28, 2025 8:00 AM EDT
Company Participants
Jonathan Dickinson - CEO & Director
Sonia Quaratino - Executive VP & Chief Medical Officer
Stéphanie Cornen
Stephanie Cornen - Vice President of Investor Relations, Communication & Commercial Strategy
Yannis Morel - Executive VP & COO
...
Read the full article on Seeking Alpha
For further details see:
Innate Pharma S.A. (IPHA) Analyst/Investor Day Transcript
Innate Pharma S.A.
NASDAQ: IPHA
IPHA Trading
-0.63% G/L:
$1.59 Last:
13,204 Volume:
$1.60 Open:
IPHA Latest News
February 19, 2026 01:00:00 am
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
February 18, 2026 01:00:00 am
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
December 22, 2025 01:00:00 am
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
IPHA Stock Data
$162,196,580
59,035,869
N/A
7
N/A
Biotechnology & Life Sciences
Healthcare
FR
Marseille
